6-Hydroxydopa
Chemical compound
6-Hydroxydopa is a chemical compound that is structurally related to the amino acid L-DOPA, which is a precursor to several important neurotransmitters in the human body. This compound is of interest in the field of neuroscience and pharmacology due to its potential effects on the nervous system.
Chemical Structure and Properties[edit | edit source]
6-Hydroxydopa is a derivative of L-DOPA, characterized by the addition of a hydroxyl group at the sixth position of the aromatic ring. This modification alters its chemical properties and biological activity. The molecular formula of 6-Hydroxydopa is C9H11NO5, and it has a molecular weight of 213.19 g/mol.
Biosynthesis and Metabolism[edit | edit source]
In biological systems, 6-Hydroxydopa can be formed through the hydroxylation of L-DOPA by specific enzymes. It is not a major metabolic product in humans but can be synthesized in certain experimental conditions. Once formed, 6-Hydroxydopa can undergo further metabolic transformations, potentially leading to the formation of other biologically active compounds.
Pharmacological Effects[edit | edit source]
The pharmacological effects of 6-Hydroxydopa are not as well-studied as those of its parent compound, L-DOPA. However, due to its structural similarity, it may interact with similar biochemical pathways. It is hypothesized that 6-Hydroxydopa could influence the synthesis and degradation of catecholamines, such as dopamine, norepinephrine, and epinephrine.
Potential Applications[edit | edit source]
Research into 6-Hydroxydopa is ongoing, with interest in its potential applications in neurodegenerative diseases such as Parkinson's disease. Its ability to modulate neurotransmitter levels could make it a candidate for therapeutic development, although more research is needed to fully understand its effects and safety profile.
Safety and Toxicity[edit | edit source]
The safety and toxicity of 6-Hydroxydopa have not been extensively studied. As with many compounds that affect neurotransmitter systems, there is a potential for both therapeutic and adverse effects. Careful evaluation in preclinical and clinical studies is necessary to determine its safety for potential therapeutic use.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
